News
Merck & Co joins KRAS gold rush with Taiho and Astex collabo...
US-based Merck & Co has forged an R&D tie-up with Taiho and Astex Pharmaceuticals, focused on developing small molecule drugs targeting the KRAS gene that has become the subject of
